JPWO2020076789A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020076789A5 JPWO2020076789A5 JP2021519612A JP2021519612A JPWO2020076789A5 JP WO2020076789 A5 JPWO2020076789 A5 JP WO2020076789A5 JP 2021519612 A JP2021519612 A JP 2021519612A JP 2021519612 A JP2021519612 A JP 2021519612A JP WO2020076789 A5 JPWO2020076789 A5 JP WO2020076789A5
- Authority
- JP
- Japan
- Prior art keywords
- antigen
- antibody
- aureus
- binding fragment
- binds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862743490P | 2018-10-09 | 2018-10-09 | |
| US62/743,490 | 2018-10-09 | ||
| US201962833297P | 2019-04-12 | 2019-04-12 | |
| US62/833,297 | 2019-04-12 | ||
| PCT/US2019/055143 WO2020076789A2 (en) | 2018-10-09 | 2019-10-08 | Combinations of anti-staphylococcus aureus antibodies |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022512647A JP2022512647A (ja) | 2022-02-07 |
| JPWO2020076789A5 true JPWO2020076789A5 (enExample) | 2022-10-18 |
Family
ID=70051346
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021519612A Ceased JP2022512647A (ja) | 2018-10-09 | 2019-10-08 | 抗黄色ブドウ球菌（Ｓｔａｐｈｙｌｏｃｏｃｃｕｓ ａｕｒｅｕｓ）抗体の組み合わせ |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US11168133B2 (enExample) |
| EP (1) | EP3864041A2 (enExample) |
| JP (1) | JP2022512647A (enExample) |
| KR (1) | KR20210072057A (enExample) |
| CN (1) | CN113164602A (enExample) |
| AU (1) | AU2019357983A1 (enExample) |
| BR (1) | BR112021006622A2 (enExample) |
| CA (1) | CA3115633A1 (enExample) |
| MX (1) | MX2021004173A (enExample) |
| TW (1) | TW202035443A (enExample) |
| WO (1) | WO2020076789A2 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104968797B (zh) * | 2012-11-06 | 2018-11-30 | 米迪缪尼有限公司 | 金黄色葡萄球菌表面决定簇的抗体 |
| TWI902669B (zh) | 2018-07-24 | 2025-11-01 | 美商麥迪紐有限責任公司 | 抗金黃色葡萄球菌凝集因子a(clfa)之抗體 |
| EP3864040A1 (en) | 2018-10-09 | 2021-08-18 | Medimmune, LLC | Antibodies directed against staphylococcus aureus leukotoxins |
| WO2020076789A2 (en) | 2018-10-09 | 2020-04-16 | Medimmune, Llc | Combinations of anti-staphylococcus aureus antibodies |
| TW202100549A (zh) | 2019-03-13 | 2021-01-01 | 美商麥迪紐有限責任公司 | 降低金黃色葡萄球菌在定殖的患者中之感染 |
| WO2021225912A1 (en) * | 2020-05-07 | 2021-11-11 | Pliant Therapeutics, Inc. | Treatment of respiratory diseases with amino acid compounds |
| CN117771379B (zh) * | 2023-10-25 | 2024-08-30 | 珠海泰诺麦博制药股份有限公司 | 特异性结合金黄色葡萄球菌Hla毒素的全人源抗体与抗生素的组合 |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6596541B2 (en) | 2000-10-31 | 2003-07-22 | Regeneron Pharmaceuticals, Inc. | Methods of modifying eukaryotic cells |
| US7658921B2 (en) | 2000-12-12 | 2010-02-09 | Medimmune, Llc | Molecules with extended half-lives, compositions and uses thereof |
| WO2002072600A2 (en) | 2001-01-26 | 2002-09-19 | Inhibitex, Inc. | Monoclonal antibodies to the clfa protein and method of use in treating or preventing infections |
| IL166244A0 (en) | 2001-07-12 | 2006-01-15 | Jefferson Foote | Super humanized antibodies |
| US20030226155A1 (en) | 2001-08-30 | 2003-12-04 | Biorexis Pharmaceutical Corporation | Modified transferrin-antibody fusion proteins |
| US20040014194A1 (en) | 2002-03-27 | 2004-01-22 | Schering Corporation | Beta-secretase crystals and methods for preparing and using the same |
| ES2338105T3 (es) | 2003-05-14 | 2010-05-04 | Kenta Biotech Ag | Anticuerpo monoclonal humano especifico para lipopolisacaridos (lps) de serotipo iats 06 pseudomonas aeruginosa. |
| CN1324049C (zh) | 2003-08-04 | 2007-07-04 | 中国疾病预防控制中心病毒病预防控制所 | 人源抗sars冠状病毒基因工程抗体 |
| CN1942483B (zh) | 2004-04-13 | 2012-09-26 | 弗·哈夫曼-拉罗切有限公司 | 抗p型选凝素抗体 |
| TW200813091A (en) | 2006-04-10 | 2008-03-16 | Amgen Fremont Inc | Targeted binding agents directed to uPAR and uses thereof |
| EP2719397A1 (en) | 2006-06-12 | 2014-04-16 | GlaxoSmithKline Biologicals SA | Use of alpha-toxin for treating and preventing staphylococcus infections |
| BRPI0807952A2 (pt) | 2007-02-20 | 2014-06-10 | Anaptysbio Inc | Sistemas de hipermutação somática |
| MX2010001918A (es) | 2007-08-21 | 2010-03-11 | Amgen Inc | Proteinas enlazadas al antigeno humano de celula de cepa mcdonough de felino. |
| AU2008292897B2 (en) | 2007-08-31 | 2015-01-22 | University Of Chicago | Methods and compositions related to immunizing against staphylococcal lung diseases and conditions |
| WO2010003108A2 (en) | 2008-07-02 | 2010-01-07 | Trubion Pharmaceuticals, Inc. | TNF-α ANTAGONIST MULTI-TARGET BINDING PROTEINS |
| EP2208787A1 (en) | 2009-01-19 | 2010-07-21 | Université de Liège | A recombinant alpha-hemolysin polypeptide of Staphylococcus aureus, having a deletion in the stem domain and heterologous sequences inserted |
| JP2012516158A (ja) | 2009-01-29 | 2012-07-19 | メディミューン，エルエルシー | 延長したインビボ半減期を有するヒト抗ｉｌ−６抗体ならびに腫瘍学、自己免疫疾患、および炎症性疾患の治療におけるそれらの使用 |
| CA3088918A1 (en) | 2010-05-05 | 2011-11-10 | New York University | Staphylococcus aureus leukocidins, therapeutic compositions, and uses thereof |
| SG10201913690SA (en) | 2011-02-08 | 2020-03-30 | Medimmune Llc | Antibodies that specifically bind staphylococcus aureus alpha toxin and methods of use |
| CN104968797B (zh) | 2012-11-06 | 2018-11-30 | 米迪缪尼有限公司 | 金黄色葡萄球菌表面决定簇的抗体 |
| KR20150092738A (ko) | 2012-11-06 | 2015-08-13 | 메디뮨 엘엘씨 | 에스.아우레우스 연관 질병의 치료 방법 |
| CN105873946A (zh) | 2013-10-17 | 2016-08-17 | 阿尔萨尼斯生物科学有限责任公司 | 交叉反应性金黄色葡萄球菌抗体序列 |
| CN106413750B (zh) | 2014-05-16 | 2022-04-29 | 免疫医疗有限责任公司 | 具有增强的治疗和诊断特性的带有改变的新生儿Fc受体结合的分子 |
| TWI719938B (zh) | 2014-06-19 | 2021-03-01 | 美商麥迪紐有限責任公司 | 多重細菌感染之治療 |
| CN107873034A (zh) * | 2015-04-17 | 2018-04-03 | 阿尔萨尼斯生物科学有限责任公司 | 抗金黄色葡萄球菌抗体组合制剂 |
| WO2017075188A2 (en) | 2015-10-30 | 2017-05-04 | Medimmune, Llc | Methods of using anti-alpha toxin antibody |
| TWI902669B (zh) | 2018-07-24 | 2025-11-01 | 美商麥迪紐有限責任公司 | 抗金黃色葡萄球菌凝集因子a(clfa)之抗體 |
| WO2020076789A2 (en) | 2018-10-09 | 2020-04-16 | Medimmune, Llc | Combinations of anti-staphylococcus aureus antibodies |
| EP3864040A1 (en) | 2018-10-09 | 2021-08-18 | Medimmune, LLC | Antibodies directed against staphylococcus aureus leukotoxins |
-
2019
- 2019-10-08 WO PCT/US2019/055143 patent/WO2020076789A2/en not_active Ceased
- 2019-10-08 US US16/596,388 patent/US11168133B2/en active Active
- 2019-10-08 KR KR1020217013653A patent/KR20210072057A/ko not_active Ceased
- 2019-10-08 CA CA3115633A patent/CA3115633A1/en active Pending
- 2019-10-08 BR BR112021006622-5A patent/BR112021006622A2/pt not_active IP Right Cessation
- 2019-10-08 EP EP19871705.0A patent/EP3864041A2/en not_active Withdrawn
- 2019-10-08 AU AU2019357983A patent/AU2019357983A1/en not_active Abandoned
- 2019-10-08 JP JP2021519612A patent/JP2022512647A/ja not_active Ceased
- 2019-10-08 TW TW108136341A patent/TW202035443A/zh unknown
- 2019-10-08 CN CN201980078574.1A patent/CN113164602A/zh active Pending
- 2019-10-08 MX MX2021004173A patent/MX2021004173A/es unknown
-
2021
- 2021-10-01 US US17/491,889 patent/US20220089699A1/en not_active Abandoned